A b s t r a c t I In nt tr ro od du uc ct ti io on n: : While studies have examined the effects of mild-moderate obesity on pulmonary function, there have been no large studies that have specifically looked at the impact of morbid obesity, especially with regard to the influence of gender and age. Some studies have demonstrated an increased incidence of asthma among obese patients, suggesting that this may be due to a decrease in airway caliber, although there is little evidence to support this. The aim of this study was to examine the impact of morbid obesity on pulmonary function with a particular emphasis on the influence of gender and age. By including a large number of patients in the study, the goal was to also get some insight into the association between obesity and asthma. M Ma at te er ri ia al l a an nd d m me et th ho od ds s: : Pulmonary function test results were collected on 433 patients with a body mass index BMI ≥40 kg/m 2 who were being evaluated for bariatric surgery between January 2001 and August 2006. R Re es su ul lt ts s: : BMI had a significant impact on the forced vital capacity (FVC), forced expiratory volume in the first second (FEV 1 ), expiratory reserve volume (ERV), residual volume (RV), total lung capacity (TLC) and partial pressure of oxygen in arterial blood (PaO 2 ). In addition, there were significant differences in pulmonary function based on the gender and age of the patient. FVC, FEV 1 , FEV 1 /FVC, ERV, TLC and PaO 2 were all significantly reduced in males compared to females. Similarly, FVC was significantly reduced among subjects >40 years when compared to those ≤40 years. C Co on nc cl lu us si io on ns s: : Our study demonstrated the effects of morbid obesity on pulmonary function. It also established the greater impact of obesity in men, which along with the absence of an obstructive impairment in almost all our patients suggests that asthma maybe being over-diagnosed in obese patients, especially women. K Ke ey y w wo or rd ds s: : morbid obesity, pulmonary function, asthma.
Introduction
About 25% of the adult U.S. population is obese while at least 5% is morbidly obese. Over the past several decades, this has been an increasing trend with some projections estimating that 20% of the population will be morbidly obese by the year 2010 [1] . This growing problem will have an enormous impact on healthcare costs in the future. Annual medical spending due to obesity already accounted for more than 9% of the total annual U.S. medical expenditures in 1998 [2] . volume (ERV) with decrements of up to 3-5% for each unit increase in BMI [3] [4] [5] [6] [7] [8] [9] . The effect of obesity on diffusing capacity of the lung for Carbon Monoxide (DLCO) appears to be somewhat more unpredictable with some studies demonstrating an increased DLCO in obese patients, possibly related to the increased pulmonary blood volume seen in such patients [3, 10, 11] .
The most common complaint of obese patients is dyspnea. Obesity can lead to dyspnea by a number of different mechanisms -a reduction in respiratory system compliance, lung volumes and peripheral airway diameter and an increase in pulmonary blood volume, ventilation-perfusion mismatch and airway hyperresponsiveness [4] [5] [6] [7] [8] [9] [12] [13] [14] . Respiratory system compliance is reduced mainly by the increased pulmonary blood volume, fatty infiltration of the chest wall and compression of the thoracic cage by the excess soft tissue. Thus, men who tend to have a central (upper body) pattern of obesity can be expected to have lower lung volumes and poorer pulmonary compliance compared to women who tend to have a peripheral (lower body) pattern of obesity [15] [16] [17] [18] . However, this has not been conclusively demonstrated in the literature. For instance, a recent study showed no significant differences between men and women for the effects of BMI on TLC, FVC, RV, ERV or DLCO [3] .
Body fat distribution in obese patients varies with age. Middle-aged men often undergo an increase in abdominal girth with relatively little change in body mass. As a result, obesity can be expected to have a greater impact on pulmonary function in older patients [19] .
Although the association between obesity and asthma remains controversial, wheezing is sometimes seen in obese patients and asthma is often diagnosed [20] . This maybe due to decrease in airway caliber secondary to the low lung volumes rather than to increased airway hyperresponsiveness [20, 21] . Obese women are more than twice as likely as men with equivalent BMIs to be diagnosed with asthma [22] . While this may be related to the effects of sex hormones, differences in the way obesity impacts men and women cannot be excluded. For instance, King et al. have suggested that central raises the possibility that obese patients are being over-diagnosed with asthma, possibly based more o n t h e i r subjective symptoms rather on objective data.
Most previous studies have examined the effects of mild and moderate obesity on pulmonary function. In addition to examining the effects of morbid obesity on pulmonary function, we also looked at the impact of age and gender on pulmonary function in the morbidly obese patient. We thereby hoped to provide some insight into the association between obesity and dyspnea as well as possible explanations for the increased incidence of asthma diagnoses among obese patients, especially women.
Material and methods
This was a retrospective study of all patients who were being evaluated for bariatric surgery at Westchester Medical Center between January 2001 and August 2006. All such patients were required to undergo a pulmonary function test (PFT) as part of their pre-operative evaluation. The height and weight of each patient was recorded at the time of their PFT, from which their BMI was calculated. Spirometry was done with the patient in a sitting position using a wedge spirometer with an X-Y recorder. Lung volumes were calculated either by the Nitrogen washout method or by Plethysmography. An arterial blood gas was obtained and the DLCO was corrected for Hemoglobin. The studies were performed with the Medgraphics Elite series plethysmograph using the BreezeSuite software. Predicted values were based on the Crapo reference values. Institutional Review Board approval was obtained.
Only subjects with a BMI ≥40 kg/m 2 were included in the analysis. Subjects were not excluded based on their smoking history or a diagnosis of asthma. Use of controller or rescue medications did not lead to exclusion from the study although patients had to have been off bronchodilators for at least 4 hours prior to pulmonary function testing. All values recorded were those prior to the administration of a bronchodilator, if used during the test.
The data were analyzed using Student's t-tests or Wilcoxon rank-sum tests to compare the patient Impact of morbid obesity on pulmonary function characteristics between two groups. Multiple linear regression analyses were conducted to investigate the effects of BMI, age and gender on pulmonary function. Significance was taken as p ≤0.05 for all tests.
Results
The records of a total of 472 morbidly obese patients who underwent PFTs as part of their evaluation for bariatric surgery were reviewed. Of these, 433 patients had a BMI ≥40 kg/m 2 . Of the 433 patients (325 female and 108 male), 244 were older than 40 years while 189 were ≤40 years (Table I ). The mean BMI was 50.2±7.5 kg/m 2 among the female subjects and 52.1±9.3 kg/m 2 among the male subjects (p=0.03). There was no difference between the BMIs of subjects >40 years and ≤40 years of age (50.7±7.8 vs. 50.7±8.3, p=0.97).
The mean FEV 1 /FVC ratio was 80.0±6.1 among the male patients while it was 82.6±5.1 among the female patients. Only 9 patients (4 male, 5 female) had an FEV 1 /FVC ratio <70%.
There were significant differences in pulmonary function based on the gender and the age of the patient. FVC, FEV 1 , FEV 1 /FVC, ERV, TLC and PaO 2 were all significantly reduced in males as compared to females (Table II) . Similarly, FVC was significantly reduced among the subjects >40 years when compared to those ≤40 years (Table III) . Although there was a significant reduction in the FEV 1 /FVC and PaO 2 among subjects >40 years, these were not considered clinically significant since these values are absolute and not percent predicted values, and are expected to decline with increasing age. 
Discussion
To our knowledge, this is the largest known study of pulmonary function in the morbidly obese population. We confirmed the well-described effects of obesity on various aspects of pulmonary function, especially on FVC, FEV 1 , TLC, ERV and PaO 2 . While some studies have demonstrated an increased DLCO in obese patients, we saw a minimal decrease in the DLCO (corrected for hemoglobin) in our patients. This decrease is possibly secondary to the slight reduction in alveolar volume seen in these patients due to their obesity. Another interesting observation that has often been seen in the morbidly obese population is that the RV is increased [26, 27] . This has been thought to be due to the fact that in morbidly obese people, the chest wall pressure-volume curve below FRC becomes flatter limiting the action of action of expiratory muscles, thus increasing the RV. However, we saw no increase in the RV in our patients, similar to the findings of Zerah et al. [12] .
In terms of the quantitative impact of obesity on the various aspects of pulmonary function, our study was similar to those previously described in the literature. Increasing BMI had no impact on the RV, a minimal impact on the TLC (0.3% decrease per unit increase in BMI), a slightly greater impact on the FVC and FEV 1 (0.6% decrease per unit increase in BMI) and the greatest impact on the ERV (2.7% Impact of morbid obesity on pulmonary function decrease per unit increase in BMI).
Studies have shown that males have a predominantly upper-body or central (abdominal) distribution of fat while females have a predominantly lower-body or peripheral (gluteal and femoral) distribution [17, 18] . The distribution of body fat has been shown to affect pulmonary function, with an abdominal fat pattern leading to a greater compression of the thoracic cage by the excess soft tissue [15, 16, 19, 28] . Our study confirmed these effects, with a significantly greater impact of the obesity on pulmonary function (FVC, FEV 1 , FEV 1 /FVC ratio, TLC, ERV and PaO 2 ) in the male subjects compared to the female subjects.
Obese patients tend to have an increase in abdominal girth with age. This effect was probably the reason for the small but significant decrease in the FVC and FEV 1 that we saw in our morbidly obese population older than 40 years.
Studies have shown that obese patients, especially women, are much more likely to be diagnosed with asthma by their physicians than non-obese patients [20, 25, 29] . A recent metaanalysis of seven studies demonstrated an increased incidence of asthma in obese individuals although all the studies used either self-reporting, physician diagnosis or use of asthma medications as the criteria for a diagnosis of asthma [30] . However, the majority of obese patients diagnosed with asthma have no objective evidence of airway hyper-responsiveness [20, 24] . Our study showed that the morbidly obese population did not have a baseline decrease in their FEV 1 /FVC ratio or an increase in their RV. Within the obese population, male patients tended to have a slightly but significantly lower FEV 1 /FVC ratio than the female patients, although both the mean values were within the normal range and only 9 patients (2%) had an FEV 1 /FVC ratio <70%. Thus our study does not lend support to the thought that obesity leads to an increased incidence of asthma. In addition, if the obesity was contributing to a decreased baseline airway caliber leading to increased airway hyper-responsiveness, then based on our data, an obese male patient would be more likely to develop asthma than an obese female subject. This is contrary to published literature which has shown that women are more than twice as likely as men with equivalent BMIs to be diagnosed with asthma [22] . Therefore, while other mechanisms might be the cause of the increased association between obesity and asthma, our study suggests that there might be an over-diagnosis of this condition in the obese population.
There are some limitations to this retrospective study. A patient's smoking history and a diagnosis of asthma were not used to exclude patients from the analysis. However despite this, we did not see any evidence of obstructive airway disease in our patients, thus only further adding evidence to our belief that asthma is over-diagnosed in the obese population. Although, a normal FEV 1 /FVC ratio does not exclude a diagnosis of asthma in these patients, one of the main theories behind the increased diagnosis of asthma in these patients has been a decreased baseline caliber of the airways. We saw T Ta ab bl le e I II II I. . Age differences in pulmonary function and gas-exchange of subjects with BMI ≥40 kg/m 2 A Ag ge e ≤ ≤4 40 0 y ye ea ar rs s A Ag ge e > >4 40 0 y ye ea ar rs s V Va al lu ue e ( (n n= =1 18 89 9) ) ( (n n= =2 
